}

More than a third of heater-cooler devices used in open heart surgery may be contaminated with deadly bacteria

06/14/2017

 

Contact: Andrea Fetchko
202-695-6090
andrea.fetchko@mslgroup.com

Liz Garman
202-365-7421
egarman@apic.org
 

More than a third of heater-cooler devices used in open heart surgery may be
contaminated with deadly bacteria

 
Portland, Ore., June 14, 2017 –Thirty-three of 89 (37 percent) heater-cooler units assessed between July 2015 and December 2016 tested positive for Mycobacterium chimaera (M. chimaera), a bacterium associated with fatal infections in open-heart surgery patients, according to new research presented at the 44th Annual Conference of the Association for Professionals in Infection Control and Epidemiology (APIC).  

 

Heater-cooler units (HCUs) control the temperature of a patient’s blood and organs during heart bypass surgery. The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) previously have issued safety warnings that a widely used brand of HCUs might be contaminated during manufacturing, putting patients at risk for life-threatening infections. Approximately 60 percent of heart bypass procedures performed in the U.S. use the brand of device associated with these infections.

The research, presented by John Rihs, VP of Laboratory Services at Special Pathogens Laboratory, advanced knowledge about the extent of colonization of M. chimaera that might be present in these units. Rihs and colleagues assessed devices already in use for the presence of non-tuberculous mycobacteria (NTM) colonization (primarily M. chimaera) in HCUs before and after decontamination. A total of 653 water samples from 89 units were tested. Samples were received from 23 hospitals in 14 states, the District of Columbia, and Canada. Thirty-three of the units (37 percent) tested positive for M. chimaera, while four units were colonized with Legionella. Researchers were surprised at how contaminated the units were, with 97 cultures deemed uninterpretable due to high levels of bacterial and fungal contamination. Multiple other strains of mycobacteria were also detected in many of the units.
 

“Our results showed M. chimera in 37 percent of units tested and is consistent with previous findings. The extent of contamination from such a rare organism in multiple units from all over the country was surprising,” said Rihs. “Some devices remained positive for M. chimera for months, indicating that disinfection can be difficult and routine testing is advisable. Beyond M. chimera, we found other NTM species, Legionella, and fungi, indicating these units are capable of supporting a diverse microbial population.”

HCUs have water tanks that provide temperature-controlled water during surgery through closed circuits. The water in the instrument does not come into direct contact with the patient. However, the water can aerosolize, and if contaminated, transmit bacteria through the air into the environment, and to the patient.

“These results highlight the importance of monitoring the decontamination and maintenance schedules of these devices to minimize the risk of patient harm,” said Linda Greene, RN, MPS, CIC, FAPIC, 2017 APIC president. “Hospitals must follow the cleaning and disinfection instructions provided in the manufacturer’s device labeling, as well as updated communications from the FDA and CDC.” 

M. chimaera is often found in soil and water but is rarely associated with infections. However, patients exposed to the bacteria through open-heart surgery can develop general and nonspecific symptoms that can often take months to emerge. As a result, diagnosis of these infections can be missed or delayed, sometimes for years, making these infections more difficult to treat.

Hospitals were instructed by the CDC and FDA to notify patients who have had open-heart surgery within the last five years that they were potentially at risk for infection. Patients were notified to seek medical advice if they were showing any symptoms or signs of infection, which can be vague or inconspicuous.

 

About APIC

APIC 2017 Annual Conference, June 14-16 in Portland, Oregon, is the most comprehensive infection prevention conference in the world, with more than 90 educational sessions and workshops led by experts from across the globe and attended by nearly 5,000 professionals. The conference aims to provide infection preventionists, physicians, researchers, epidemiologists, educators, administrators, and medical technologists with the latest science, technologies, and best practices for creating a safer world through prevention of infection. Join the conversation online with the hashtag #APIC2017.

 

APIC’s mission is to create a safer world through prevention of infection. The association’s more than 15,000 members direct infection prevention programs that save lives and improve the bottom line for hospitals and other healthcare facilities. APIC advances its mission through patient safety, implementation science, competencies and certification, advocacy, and data standardization. Visit APIC online at www.apic.org. Follow APIC on Twitter: www.twitter.com/apic and Facebook: www.facebook.com/APICInfectionPreventionandYou. For information on what patients and families can do, visit APIC’s Infection Prevention and You website at www.apic.org/infectionpreventionandyou

 

# # #

Contact Info

Liz Garman

202-454-2604
egarman@apic.org